Literature DB >> 14581176

Effects of insulin on vascular responses to spinal cord stimulation and vasoactive agents in pithed rats.

Shingo Takatori1, Masako Mizote, Yoshito Zamami, Yuji Kurosaki, Hiromu Kawasaki.   

Abstract

1. Effects of insulin (2-600 pmol kg(-1) min(-1), i.v.) on vascular responses to spinal cord (lower thoracic vertebra, Th 9-12) stimulation (SCS) and to i.v. injection of noradrenaline (NA, 125-500 ng kg-1), angiotensin II (Ang II, 40-200 pmol kg(-1), acetylcholine (ACh, 1 nmol kg(-1), calcitonin gene-related peptide (CGRP, 0.1 nmol kg(-1) and sodium nitroprusside (SNP, 5 microg kg-1) were examined in pithed rats. 2.In euglycemic pithed rats, low and medium doses of insulin dose-dependently potentiated vasopressor responses to SCS (2-8 Hz), NA, while higher doses of insulin had little effect on SCS- and NA-induced pressor responses. All doses of insulin significantly augmented pressor responses to Ang II. 3. In pithed rats with artificially increased blood pressure, SCS (2 and 4 Hz) induced a frequency-dependent depressor response, which was blocked by infusion of CGRP(8-37) (CGRP receptor antagonist, 60 nmol kg(-1) min(-1). 4. In euglycemic pithed rats, low-doses of insulin significantly attenuated depressor responses to SCS and CGRP, but medium and high doses of insulin remained unaffected. 5. All doses of insulin significantly inhibited depressor response to ACh, while SNP-induced depressor response was not significantly affected by any doses of insulin. 6. These results suggest that insulin at low and medium concentrations increases adrenergic vasoconstriction, which is partly associated with inhibition of CGRPergic nerve function and endothelium function. It is also suggested that lack of insulin effect at higher concentrations may result from acute desensitization of insulin action, possibly via insulin receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581176      PMCID: PMC1574125          DOI: 10.1038/sj.bjp.0705539

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Insulin inhibits acetylcholine responses in rat isolated mesenteric arteries via a non-nitric oxide nonprostanoid pathway.

Authors:  Masahiko Kimura; Ann-Maree Jefferis; Hiroshi Watanabe; Jaye Chin-Dusting
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

2.  Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat.

Authors:  H Kawasaki; K Takasaki; A Saito; K Goto
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

3.  Insulin resistance is a characteristic feature of primary hypertension independent of obesity.

Authors:  T Pollare; H Lithell; C Berne
Journal:  Metabolism       Date:  1990-02       Impact factor: 8.694

Review 4.  The effect of insulin on renal sodium metabolism. A review with clinical implications.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

5.  Beta adrenergic-mediated vasodilator response to insulin in the human forearm.

Authors:  M A Creager; C S Liang; J D Coffman
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

Review 6.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

7.  EDHF-mediated relaxation is impaired in fructose-fed rats.

Authors:  P V Katakam; M R Ujhelyi; A W Miller
Journal:  J Cardiovasc Pharmacol       Date:  1999-09       Impact factor: 3.105

8.  Insulin resistance in essential hypertension.

Authors:  E Ferrannini; G Buzzigoli; R Bonadonna; M A Giorico; M Oleggini; L Graziadei; R Pedrinelli; L Brandi; S Bevilacqua
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

9.  Effect of insulin on central catecholamines.

Authors:  A Sauter; M Goldstein; J Engel; K Ueta
Journal:  Brain Res       Date:  1983-02-07       Impact factor: 3.252

10.  Calcitonin gene-related peptide is a potent vasodilator.

Authors:  S D Brain; T J Williams; J R Tippins; H R Morris; I MacIntyre
Journal:  Nature       Date:  1985 Jan 3-9       Impact factor: 49.962

View more
  2 in total

1.  Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia.

Authors:  S Takatori; Y Zamami; N Yabumae; N Hanafusa; M Mio; T Egawa; H Kawasaki
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

Review 2.  Modulation of Sensory Nerve Function by Insulin: Possible Relevance to Pain, Inflammation and Axon Growth.

Authors:  Bence András Lázár; Gábor Jancsó; Péter Sántha
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.